British drugmaker Indivior has agreed to buy Opiant, a US biotech specializing in treatments for addiction and drug overdose. Indivior will pay about $145 million upfront...
The European Commission proposed last month an emergency intervention in Europe’s energy markets to address recent dramatic price rises as the EU faces the effects of a...
24.11.2017
- In a suit filed in the state of Delaware, the Swiss-based Roche Holding is suing Pfizer to block the future marketing a biosimilar of its breast-cancer drug Herceptin in the US...
27.09.2017
- The market for active pharmaceutical ingredients (APIs) is approximately $140 billion and is projected to reach nearly $190 billion by 2020. So what does the market show? The API...
18.09.2017
- An older version of a thyroid drug made by Merck Serono is planned to be reintroduced in France after more than 9,000 of the country's three million users complained of serious...
12.07.2017
- LifeArc, the UK medical research charity previously known as MRC Technology, is to collaborate with the government’s Defence Science and Technology Laboratory (Dstl) and Canada’s...
12.07.2017
- The US Food and Drug Administration (FDA) has placed a clinical hold on three phase 3 multiple myeloma studies testing US drugmaker Merck’s Keytruda (pembrolizumab) in combination...
22.06.2017
- In unusually open criticism of a sector journalists report on widely, the digital communications platform ISEBOX has accused the international pharmaceutical industry of failing to...
